Showing results (1991-2000 of 2,093) with videos related to

Sort By:
Pageof 210
Journal of Cancer Research and Clinical Oncology|April 2, 2023
Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approachS Gordon, D L H Chan, E J Bernard, et al.
The Lancet. Oncology|March 14, 2018
Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trialToni K Choueiri, James Larkin, Mototsugu Oya, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 21, 2018
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general populationChris Kay, Jennifer A Collins, Galen E B Wright, et al.
Contemporary Clinical Trials Communications|April 3, 2023
A proof-of-concept randomized crossover clinical trial of a first-in-class vasopressin 1a receptor antagonist for PTSD: Design, methods, and recruitmentJoAnn Difede, Andrew A McAleavey, Mariel Emrich, et al.
Plos One|February 23, 2016
Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder CancerDouglas G Ward, Laura Baxter, Naheema S Gordon, et al.
Molecular Carcinogenesis|May 2, 2024
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltrationAlice N Weaver, Wade T Iams, Jong Chul Park, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1996
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDSP K Sharkey, J R Graybill, E S Johnson, et al.
British Journal of Cancer|September 11, 2020
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancerMartin H Voss, Michael S Gordon, Monica Mita, et al.
Mucosal Immunology|November 5, 2015
miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammationS E M Heinsbroek, M L Squadrito, R Schilderink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA Targeted Tubulysin Conjugate EC1169Samir Zaidi, Phillip H Kuo, Tiago Paiva Prudente, et al.
Pageof 210